Imran is a partner at Action Potential Venture Capital in Cambridge, MA and invests in companies that are pioneering bioelectronic medicines and technologies. Imran is a Board member of Neuspera Medical, SetPoint Medical and Qionics.
Before joining Action Potential, Imran was in the Worldwide Business Development group of GlaxoSmithKline working in a variety of business development and investing roles. Imran led the establishment of and headed up the Investment Management practice at GSK. The group was tasked with accessing technology and innovation external to GSK by making and managing investments in life science venture capital funds as limited partners and direct investments in biotechs made as part of GSK’s R&D collaborations. During his tenure the group led GSK’s commitments in excess of $200 million in a number of venture capital groups as well as participated in a number of biotech IPOs.
Imran received his bachelor’s degree in finance from Concordia University in Montreal and has trained as a Canadian Chartered Accountant.
Imran currently serves on the Board of Ambassadors of the Brooke Charter School a K-8 public charter school network in Boston, MA dedicated to getting underserved students to and through college.
Juan-Pablo is a partner at Action Potential Venture Capital in Palo Alto, CA, and invests in companies that are pioneering bioelectronic medicines. Juan-Pablo is a Board member of Saluda Medical, SetPoint Medical, Neuspera Medical, Cala Health, CVRx, and Presidio Medical. He was previously an investor at Morgenthaler Ventures and Lightstone Ventures, where he focused on therapeutic medical devices, digital health, and biopharmaceutical investments. There he served as a Board observer at Ardian (acquired by Medtronic), Twelve (acquired by Medtronic), Holaira, Cabochon Aesthetics (acquired by Ulthera/Merz), and Miramar Labs.
Prior to investing, Juan-Pablo led efforts in R&D and Strategy in Medtronic’s CardioVascular Division, including Pipeline Strategy, White-Space expansion, Business Development, and M&A integration efforts. He was named “Medtronic Inventor of The Year” in 2008, and has 30+ patents, granted or pending. Subsequently, he served on the Global Brand Strategy team at Eli Lilly within the Cardiovascular business.
Juan-Pablo earned an MBA from Stanford Graduate School of Business. He conducted research in the Neuroscience Department, and in the Neurology Department at Stanford Hospital, while completing an M.S. in Electrical Engineering at Stanford University. He received his B.S. in Electrical Engineering from the University of Massachusetts, Amherst.
Juan-Pablo currently serves on the Board of Directors of the Boston-based non-profit, InnerCity Weightlifting, where the gym is used to replace segregation and isolation with economic mobility and social inclusion, disrupting the system that leads to urban street violence.